206 related articles for article (PubMed ID: 11888575)
1. How strong is the evidence that brain serotonin neurons are damaged in human users of ecstasy?
Kish SJ
Pharmacol Biochem Behav; 2002 Apr; 71(4):845-55. PubMed ID: 11888575
[TBL] [Abstract][Full Text] [Related]
2. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
[TBL] [Abstract][Full Text] [Related]
3. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users.
Thomasius R; Petersen K; Buchert R; Andresen B; Zapletalova P; Wartberg L; Nebeling B; Schmoldt A
Psychopharmacology (Berl); 2003 Apr; 167(1):85-96. PubMed ID: 12632248
[TBL] [Abstract][Full Text] [Related]
4. Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?
Gouzoulis-Mayfrank E; Daumann J
Addiction; 2006 Mar; 101(3):348-61. PubMed ID: 16499508
[TBL] [Abstract][Full Text] [Related]
5. Brain serotonin transporter binding in former users of MDMA ('ecstasy').
Selvaraj S; Hoshi R; Bhagwagar Z; Murthy NV; Hinz R; Cowen P; Curran HV; Grasby P
Br J Psychiatry; 2009 Apr; 194(4):355-9. PubMed ID: 19336788
[TBL] [Abstract][Full Text] [Related]
6. [Psychiatric and cognitive long-term effects of ecstasy].
Høiseth G; Løvåsdal Ø; Titze TK; Bramness JG; Bachs L
Tidsskr Nor Laegeforen; 2006 Feb; 126(5):596-8. PubMed ID: 16505868
[TBL] [Abstract][Full Text] [Related]
7. Long-term effects of "ecstasy" use on serotonin transporters of the brain investigated by PET.
Buchert R; Thomasius R; Nebeling B; Petersen K; Obrocki J; Jenicke L; Wilke F; Wartberg L; Zapletalova P; Clausen M
J Nucl Med; 2003 Mar; 44(3):375-84. PubMed ID: 12621003
[TBL] [Abstract][Full Text] [Related]
8. Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence?
Morgan MJ; McFie L; Fleetwood H; Robinson JA
Psychopharmacology (Berl); 2002 Jan; 159(3):294-303. PubMed ID: 11862362
[TBL] [Abstract][Full Text] [Related]
9. Reversibility of ecstasy-induced reduction in serotonin transporter availability in polydrug ecstasy users.
Buchert R; Thomasius R; Petersen K; Wilke F; Obrocki J; Nebeling B; Wartberg L; Zapletalova P; Clausen M
Eur J Nucl Med Mol Imaging; 2006 Feb; 33(2):188-99. PubMed ID: 16133393
[TBL] [Abstract][Full Text] [Related]
10. A voxel-based PET investigation of the long-term effects of "Ecstasy" consumption on brain serotonin transporters.
Buchert R; Thomasius R; Wilke F; Petersen K; Nebeling B; Obrocki J; Schulze O; Schmidt U; Clausen M
Am J Psychiatry; 2004 Jul; 161(7):1181-9. PubMed ID: 15229049
[TBL] [Abstract][Full Text] [Related]
11. Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy") polydrug users.
Fox HC; McLean A; Turner JJ; Parrott AC; Rogers R; Sahakian BJ
Psychopharmacology (Berl); 2002 Jul; 162(2):203-14. PubMed ID: 12110998
[TBL] [Abstract][Full Text] [Related]
12. Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[(11)C]DASB and structural brain imaging study.
Kish SJ; Lerch J; Furukawa Y; Tong J; McCluskey T; Wilkins D; Houle S; Meyer J; Mundo E; Wilson AA; Rusjan PM; Saint-Cyr JA; Guttman M; Collins DL; Shapiro C; Warsh JJ; Boileau I
Brain; 2010 Jun; 133(Pt 6):1779-97. PubMed ID: 20483717
[TBL] [Abstract][Full Text] [Related]
13. [Acute and long-term effects of ecstasy].
Salzmann J; Marie-Claire C; Noble F
Presse Med; 2004 Oct; 33(18 Suppl):24-32. PubMed ID: 15617173
[TBL] [Abstract][Full Text] [Related]
14. Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings.
McCann UD; Szabo Z; Scheffel U; Dannals RF; Ricaurte GA
Lancet; 1998 Oct; 352(9138):1433-7. PubMed ID: 9807990
[TBL] [Abstract][Full Text] [Related]
15. Event related potential (ERP) evidence for selective impairment of verbal recollection in abstinent recreational methylenedioxymethamphetamine ("Ecstasy")/polydrug users.
Burgess AP; Venables L; Jones H; Edwards R; Parrott AC
Psychopharmacology (Berl); 2011 Aug; 216(4):545-56. PubMed ID: 21390504
[TBL] [Abstract][Full Text] [Related]
16. Altered states: the clinical effects of Ecstasy.
Cole JC; Sumnall HR
Pharmacol Ther; 2003 Apr; 98(1):35-58. PubMed ID: 12667887
[TBL] [Abstract][Full Text] [Related]
17. Long-term effects of 'ecstasy' abuse on the human brain studied by FDG PET.
Buchert R; Obrocki J; Thomasius R; Väterlein O; Petersen K; Jenicke L; Bohuslavizki KH; Clausen M
Nucl Med Commun; 2001 Aug; 22(8):889-97. PubMed ID: 11473208
[TBL] [Abstract][Full Text] [Related]
18. Memory performance in polyvalent MDMA (ecstasy) users who continue or discontinue MDMA use.
Gouzoulis-Mayfrank E; Fischermann T; Rezk M; Thimm B; Hensen G; Daumann J
Drug Alcohol Depend; 2005 Jun; 78(3):317-23. PubMed ID: 15893163
[TBL] [Abstract][Full Text] [Related]
19. Differences in prefrontal blood oxygenation during an acute multitasking stressor in ecstasy polydrug users.
Roberts CA; Wetherell MA; Fisk JE; Montgomery C
Psychol Med; 2015 Jan; 45(2):395-406. PubMed ID: 25066866
[TBL] [Abstract][Full Text] [Related]
20. Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA; 'ecstasy').
McCann UD; Slate SO; Ricaurte GA
Drug Saf; 1996 Aug; 15(2):107-15. PubMed ID: 8884162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
